Clevenbergh P - Search Results

1

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan.

DeGruttola V, Dix L, D'Aquila R, Holder D, Phillips A, Ait-Khaled M, Baxter J, Clevenbergh P, Hammer S, Harrigan R, Katzenstein D, Lanier R, Miller M, Para M, Yerly S, Zolopa A, Murray J, Patick A, Miller V, Castillo S, Pedneault L, Mellors J. DeGruttola V, et al. Among authors: clevenbergh p. Antivir Ther. 2000 Mar;5(1):41-8. doi: 10.1177/135965350000500112. Antivir Ther. 2000. PMID: 10846592

2

Updated European recommendations for the clinical use of HIV drug resistance testing.

Vandamme AM, Sönnerborg A, Ait-Khaled M, Albert J, Asjo B, Bacheler L, Banhegyi D, Boucher C, Brun-Vézinet F, Camacho R, Clevenbergh P, Clumeck N, Dedes N, De Luca A, Doerr HW, Faudon JL, Gatti G, Gerstoft J, Hall WW, Hatzakis A, Hellmann N, Horban A, Lundgren JD, Kempf D, Miller M, Miller V, Myers TW, Nielsen C, Opravil M, Palmisano L, Perno CF, Phillips A, Pillay D, Pumarola T, Ruiz L, Salminen M, Schapiro J, Schmidt B, Schmit JC, Schuurman R, Shulse E, Soriano V, Staszewski S, Vella S, Youle M, Ziermann R, Perrin L. Vandamme AM, et al. Among authors: clevenbergh p. Antivir Ther. 2004 Dec;9(6):829-48. Antivir Ther. 2004. PMID: 15651743

3

Persisting long-term benefit of genotype-guided treatment for HIV-infected patients failing HAART. The Viradapt Study: week 48 follow-up.

Clevenbergh P, Durant J, Halfon P, del Giudice P, Mondain V, Montagne N, Schapiro JM, Boucher CA, Dellamonica P. Clevenbergh P, et al. Antivir Ther. 2000 Mar;5(1):65-70. Antivir Ther. 2000. PMID: 10846595 Clinical Trial.

4

Long-term virological outcome in patients infected with multi-nucleoside analogue-resistant HIV-1.

Clevenbergh P, Kirstetter M, Liotier JY, Dupon M, Philibert P, Jacomet C, Cua E, Montagne N, Schmit JC, Dellamonica P. Clevenbergh P, et al. Antivir Ther. 2002 Dec;7(4):305-8. Antivir Ther. 2002. PMID: 12553486

5

Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.

De Luca A, Giambenedetto SD, Trotta MP, Colafigli M, Prosperi M, Ruiz L, Baxter J, Clevenbergh P, Cauda R, Perno CF, Antinori A. De Luca A, et al. Among authors: clevenbergh p. J Infect Dis. 2007 Dec 1;196(11):1645-53. doi: 10.1086/522231. Epub 2007 Oct 26. J Infect Dis. 2007. PMID: 18008248

6

Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study.

Chaix C, Grenier-Sennelier C, Clevenbergh P, Durant J, Schapiro JM, Dellamonica P, Durand-Zaleski I. Chaix C, et al. Among authors: clevenbergh p. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):227-31. doi: 10.1097/00126334-200007010-00005. J Acquir Immune Defic Syndr. 2000. PMID: 10969346 Clinical Trial.

7

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

Durant J, Clevenbergh P, Halfon P, Delgiudice P, Porsin S, Simonet P, Montagne N, Boucher CA, Schapiro JM, Dellamonica P. Durant J, et al. Among authors: clevenbergh p. Lancet. 1999 Jun 26;353(9171):2195-9. doi: 10.1016/s0140-6736(98)12291-2. Lancet. 1999. PMID: 10392984 Clinical Trial.

8

Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.

Clevenbergh P, Mouly S, Sellier P, Badsi E, Cervoni J, Vincent V, Trout H, Bergmann JF. Clevenbergh P, et al. Curr HIV Res. 2004 Oct;2(4):309-21. doi: 10.2174/1570162043351129. Curr HIV Res. 2004. PMID: 15544452 Review.

9

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.

Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, Del Giudice P, Montagne N, Schapiro JM, Dellamonica P. Durant J, et al. Among authors: clevenbergh p. AIDS. 2000 Jul 7;14(10):1333-9. doi: 10.1097/00002030-200007070-00005. AIDS. 2000. PMID: 10930147 Clinical Trial.

10

HIV resistance to antiretroviral drugs: mechanisms, genotypic and phenotypic resistance testing in clinical practice.

Blaise P, Clevenbergh P, Vaira D, Moutschen M, Dellamonica P. Blaise P, et al. Among authors: clevenbergh p. Acta Clin Belg. 2002 Jul-Aug;57(4):191-201. doi: 10.1179/acb.2002.041. Acta Clin Belg. 2002. PMID: 12462795 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters